Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113)

PHASE4CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Pain

Interventions

DRUG

etoricoxib

etoricoxib 60 mg QD for 4 weeks.

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00757627 - Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113) | Biotech Hunter | Biotech Hunter